New Evidence in Worsening Heart Failure: Examining Implications for Managed Care
New Evidence in Worsening Heart Failure: Examining Implications for Managed Care is organized by Prime Education, LLC.
Release Date: April 21, 2023
Expiration Date: April 20, 2024
Description:
Worsening heart failure has significant economic impact with high rates of hospitalization, morbidity, and mortality. Tune in to this recording of the symposium from the Academy of Managed Care Pharmacy (AMCP) annual meeting to hear leading experts discuss the latest clinical evidence on new and emerging treatments for worsening heart failure and applications for managed care decision-making to improve outcomes for patients with this complex disease.
Don't miss this opportunity to:
• See NEW real-world survey data from managed care professionals
• Gain real-world insights into unmet patient needs, health disparities, and treatment considerations for worsening heart failure
• This activity is delivered in partnership with the AMCP Foundation.
Agenda:
• The Clinical and Economic Impact of Worsening Heart Failure (WHF)
• Differentiating New and Emerging Therapies for WHF
• Case-Based Discussions on GDMT to Inform Managed Care Decision-Making
• Managed Care Strategies to Overcome Disparities in HF Treatment
• Question-and-Answer Session
Learning Objectives:
• Examine the impact of worsening heart failure (WHF) on healthcare utilization and patient outcomes
• Assess data related to real-world adherence to guideline-directed medical therapy (GDMT) that drive healthcare disparities in heart failure
• Differentiate new and emerging therapies for HF based on mechanism of action, safety, efficacy, and cost-effectiveness data
• Align managed care decision-making with current evidence, treatment guidelines, and patient factors to ensure appropriate patient selection and equitable access to therapies for heart failure